Court Overseeing Federal Testosterone Treatment Lawsuits Issues New Case Management Order, Bernstein Liebhard LLP Reports

Share Article

The federal litigation underway in Illinois includes hundred of testosterone lawsuits filed on behalf of men who suffered heart attacks, strokes, and other life-threatening cardiovascular events, allegedly due to their use of low testosterone therapy.

Free Case Review
Our Firm is in the process of evaluating a number of claims on behalf of men who allegedly suffered heart attacks, strokes and other life-threatening cardiovascular events due to their use of low testosterone therapy.

Testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) filed on behalf of men who were allegedly harmed by AndroGel and similar drugs continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a new Case Management Order issued on December 13th, the Court has established procedures to facilitate the coordination of testosterone lawsuits pending in the federal proceeding with those that have been filed in state courts. Among other things, the Order directs the Plaintiffs’ Steering Committee for the federal litigation to coordinate discovery with state court proceedings to the furthest extent possible. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is in the process of evaluating a number of claims on behalf of men who allegedly suffered heart attacks, strokes and other life-threatening cardiovascular events due to their use of low testosterone therapy. We are pleased to see the federal proceeding moving forward, and will continue to monitor the progress of this litigation as we head into the new year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating legal claims on behalf of men who were allegedly harmed by AndroGel and other testosterone treatments.

Testosterone Treatment Litigation
According to court documents, more than 270 testosterone treatment lawsuits are now pending in the federal litigation underway in the Northern District of Illinois. All of the claims allege that this class of medications is associated with an increased risk of heart attack, stroke and other serious cardiovascular side effects. Among other things, the complaints claim that sales of testosterone replacement products were driven by deceptive marketing tactics that induced many healthy men to use the drugs in the absence of a true medical need. Plaintiffs further allege that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential risks, and concealed those dangers from the public.

Testosterone lawsuits began mounting in U.S. courts following the Food & Drug Administration’s (FDA) January announcement that it was evaluating the cardiovascular risks associated with low testosterone therapy. Since then, a panel of FDA advisors recommended that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other age-related symptoms. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

Men who allegedly suffered heart attacks, stroke, deep vein thrombosis, pulmonary embolism or other serious cardiovascular problems due to their use of prescription testosterone therapies may be entitled to join this growing litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website